Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone

Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Saniee, Sara, Davarnia, Ghazaleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156886/
https://www.ncbi.nlm.nih.gov/pubmed/27990110
http://dx.doi.org/10.1159/000452319
_version_ 1782481345113489408
author Saniee, Sara
Davarnia, Ghazaleh
author_facet Saniee, Sara
Davarnia, Ghazaleh
author_sort Saniee, Sara
collection PubMed
description Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone.
format Online
Article
Text
id pubmed-5156886
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-51568862016-12-16 Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone Saniee, Sara Davarnia, Ghazaleh Case Rep Dermatol Single Case Scleromyxedema is a rare and distinctive variant of cutaneous mucinoses of unknown etiology. It is presenting with generalized papular eruption and sclerodermoid induration. Numerous treatment modalities have been reported to produce partial or permanent responses. This study reports on a case of scleromyxedema without paraproteinemia in a subject who experienced a partial response to thalidomide and prednisolone. S. Karger AG 2016-11-21 /pmc/articles/PMC5156886/ /pubmed/27990110 http://dx.doi.org/10.1159/000452319 Text en Copyright © 2016 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Single Case
Saniee, Sara
Davarnia, Ghazaleh
Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_full Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_fullStr Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_full_unstemmed Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_short Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
title_sort scleromyxedema without paraproteinemia: treatment with thalidomide and prednisolone
topic Single Case
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156886/
https://www.ncbi.nlm.nih.gov/pubmed/27990110
http://dx.doi.org/10.1159/000452319
work_keys_str_mv AT sanieesara scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone
AT davarniaghazaleh scleromyxedemawithoutparaproteinemiatreatmentwiththalidomideandprednisolone

Ejemplares similares